Skip to content

NSAIDs INFLUENCE ON HEAL OF COLLES FRACTURE - NSAID's study

NSAIDs INFLUENCE ON HEAL OF COLLES FRACTURE - NSAID's study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-018543-34-DK
Enrollment
192
Registered
2010-03-22
Start date
2010-06-11
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ivestigations hypotheses: 1. NSAIDs provide a significant postoperative pain relief that can make mobilization / rehabilitation faster and easier oedema prophylaxis. 2. NSAIDs do not affect bone healing or affect so little that it will not lead to consequences (delayed or absent healing, osteoporosis, instability) of clinical significance. 3. Radiological assessment of secondary dislocation of fractures, DEXA - scanning and bone marker tests are equally sensitive to detect bone effects. MedDRA

Interventions

Trade Name: Ibumetin Product Name: Ibumetin Pharmaceutical Form: Tablet INN or Proposed INN: IBUPROFEN CAS Number: 15687-27-1 Current Sponsor code: 12153599 Other descriptive name: Ibumetin Concentrat

Sponsors

Orthopaedic Syrgery Unit Northern Jytland
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Written acceptance to participate in the study, reposition and / or surgery demanding Colles fracture, which needs to be fixed with external fixation. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Age - younger than 50 years or older than 80 years; treatment with prednisolon; NSAIDs - treatment; previous fracture or surgery at the wrist; lack of mental and physical capacity to follow studies’ instructions; lack of informed consent; other diseases can affect bone substance (oncology, endocrine diseases), medical contraindications to NSAIDs use, smoking, alcohol consumption more than 14 drinks per week, secondary dislocation of fracture also apply as exclusion criterion.

Design outcomes

Primary

MeasureTime frame
Main Objective: Primary point: assessment of radiological secondary dislocation: any migration larger than in the other group will be an expression of instability and thus slower or absent healing. It is possible to determine the migration of approx. 0.5 mm and 1 ° accuracy. Incidence of secondary dislocations and those, which need an operation, will be manufactured in absolute and percentage figures. ;Secondary Objective: Secondary points: movements of the wrist joint, DASH (function) score; pain measured by VAS-score (patients complete pain diary in the first 2 weeks postoperatively); noted consumption of painkillers, which is prescribed ‘as needed’; Bone mineral density measured by DEXA scanner: it will be examined whether there are significant differences between density measurement of healthy radius at the beginning of treatment and 3 months later, is there a significant difference between broken and healthy bone mineralization; bone markers: Serum Cross Laps ELISA ®, N-Mid ® Osteocalcin ELISA; bone biopsy from callus zone: assessed ossification and maturity of the callus , which are presented in histomorphometric numbers: bone and fibrous tissue volume fraction, osteoid thickness. ;Primary end point(s): Primary point: assessment of radiological secondary dislocation: any migration larger than in the other group will be an expression of instability and thus slower or absent healing. It is possible to determine the migration of approx. 0.5 mm and 1 ° accuracy. Incidence of secondary dislocations and those, which need an operation, will be manufactured in absolute and percentage figures. Secondary points: movements of the wrist joint, DASH (function) score; pain measured by VAS-score (patients complete pain diary in the first 2 weeks postoperatively); noted consumption of painkillers, which is prescribed ‘as needed’; Bone mineral density measured by DEXA scanner: it will be examined whether there are significant differences between density measurement of

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026